OTIBLOCK

OTIBLOCK Pack                                                                               

THE CONDITION

Earwax removal is the most common Ear, Nose, and Throat procedure performed in the primary care setting. Clinical manifestations of an earwax impaction include pain, itching, sensation of fullness, tinnitus, odour, drainage, cough, dizziness, significant hearing loss (in case of complete occlusion).

Twelve million people seek medical care annually for problematic earwax in the United States, resulting in nearly 8 million earwax removal procedures.

Approximately 2% to 6% of the general population in the United Kingdom suffers from earwax impaction at any given time.

 

PRODUCT PROFILE

 

OTIBLOCK® is a new Medical Device consisting in a solution that softens and helps the earwax impaction removal.

Furthermore, OTIBLOCK® impedes the bacterial overgrowth by means of a particular mechanism of action decreasing the risk of External Otitis in more susceptible patients.

 

DOSAGE FORMS

OTIBLOCK® is supplied in a 45 ML spray with cannula for a more convenient self-administration.

REGULATORY STATUS

OTIBLOCK® is classified as a Class I Medical Device, and obtained the CE Mark in July 2015.

 

FOR MORE INFORMATION VISIT: WWW.OTIBLOCK.COM